Healthcare provider profile · identity verified

Jagadish C Malakar, M.D.

Internal Medicine · CORTLAND, NY · NPI 1700879640

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	390	95
Metoprolol Succinate	Metoprolol Succinate	366	106
Amlodipine Besylate	Amlodipine Besylate	348	97
Albuterol Sulfate Hfa	Albuterol Sulfate	315	110
Atorvastatin Calcium	Atorvastatin Calcium	294	86
Omeprazole	Omeprazole	285	79
Rosuvastatin Calcium	Rosuvastatin Calcium	258	77
Losartan Potassium	Losartan Potassium	250	68
Furosemide	Furosemide	206	67
Prednisone	Prednisone	181	101
Lisinopril	Lisinopril	170	50
Pantoprazole Sodium	Pantoprazole Sodium	159	47
Simvastatin	Simvastatin	156	43
Ozempic	Semaglutide	153	30
Gabapentin	Gabapentin	149	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	146	21
Pravastatin Sodium	Pravastatin Sodium	144	35
Metformin Hcl Er	Metformin Hcl	128	39
Eliquis	Apixaban	123	34
Allopurinol	Allopurinol	119	33
Tamsulosin Hcl	Tamsulosin Hcl	109	37
Potassium Chloride	Potassium Chloride	104	35
Tramadol Hcl	Tramadol Hcl	96	29
Alprazolam	Alprazolam	94	22
Clopidogrel	Clopidogrel Bisulfate	87	27
Fluticasone Propionate	Fluticasone Propionate	85	39
Sertraline Hcl	Sertraline Hcl	79	25
Escitalopram Oxalate	Escitalopram Oxalate	77	23
Oxycodone Hcl	Oxycodone Hcl	71	suppressed
Tizanidine Hcl	Tizanidine Hcl	69	18
Trazodone Hcl	Trazodone Hcl	66	17
Celecoxib	Celecoxib	62	18
Lovastatin	Lovastatin	61	19
Buspirone Hcl	Buspirone Hcl	60	15
Metformin Hcl	Metformin Hcl	56	19
Citalopram Hbr	Citalopram Hydrobromide	55	14
Donepezil Hcl	Donepezil Hcl	55	14
Glimepiride	Glimepiride	55	16
Zolpidem Tartrate	Zolpidem Tartrate	55	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	17
Glipizide	Glipizide	53	17
Bupropion Hcl Sr	Bupropion Hcl	52	14
Hydrochlorothiazide	Hydrochlorothiazide	52	17
Spironolactone	Spironolactone	52	18
Ezetimibe	Ezetimibe	49	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	14
Paroxetine Hcl	Paroxetine Hcl	49	11
Telmisartan	Telmisartan	49	16
Torsemide	Torsemide	49	18
Ibuprofen	Ibuprofen	48	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	45	19
Glipizide Er	Glipizide	45	16
Hydralazine Hcl	Hydralazine Hcl	45	14
Oxybutynin Chloride Er	Oxybutynin Chloride	45	12
Famotidine	Famotidine	43	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	42	17
Diazepam	Diazepam	41	suppressed
Duloxetine Hcl	Duloxetine Hcl	41	suppressed
Lorazepam	Lorazepam	41	15
Amiodarone Hcl	Amiodarone Hcl	40	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Montelukast Sodium	Montelukast Sodium	39	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	11
Jardiance	Empagliflozin	37	14
Nifedipine Er	Nifedipine	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	11
Finasteride	Finasteride	35	11
Trulicity	Dulaglutide	35	suppressed
Azithromycin	Azithromycin	34	26
Dilt-Xr	Diltiazem Hcl	34	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Nystatin	Nystatin	32	13
Bupropion Xl	Bupropion Hcl	31	suppressed
Meloxicam	Meloxicam	31	14
Mirtazapine	Mirtazapine	31	suppressed
Carbamazepine	Carbamazepine	30	suppressed
Cephalexin	Cephalexin	30	23
Levetiracetam	Levetiracetam	30	suppressed
Terazosin Hcl	Terazosin Hcl	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	17
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	12
Metoprolol Tartrate	Metoprolol Tartrate	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	17
Nitroglycerin	Nitroglycerin	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	11
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Ibandronate Sodium	Ibandronate Sodium	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Colchicine	Colchicine	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Midodrine Hcl	Midodrine Hcl	23	suppressed
Nebivolol Hcl	Nebivolol Hcl	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Methadone Hcl	Methadone Hcl	22	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	20	suppressed
Atenolol	Atenolol	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Mupirocin	Mupirocin	20	11
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Cholestyramine	Cholestyramine (With Sugar)	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	13
Enalapril Maleate	Enalapril Maleate	17	suppressed
Risperidone	Risperidone	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Amoxicillin	Amoxicillin	16	13
Clonidine Hcl	Clonidine Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Digoxin	Digoxin	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Ramipril	Ramipril	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Carvedilol	Carvedilol	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Promethegan	Promethazine Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Repatha Syringe	Evolocumab	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Vraylar	Cariprazine Hcl	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Paroxetine Er	Paroxetine Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Repaglinide	Repaglinide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error